Eversept Partners »

Viatris shares owned by Eversept Partners

Quarter-by-quarter ownership of Viatris (VTRS) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Viatris

Tip: Access up to 7 years of quarterly data

All positions including Viatris held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viatris by Eversept Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $16M 1.3M 11.94

More positions owned by Eversept Partners

Natera (NTRA)
GSK Sponsored Adr (GSK)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Inspire Med Sys (INSP)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Vera Therapeutics Cl A (VERA)
Syndax Pharmaceuticals (SNDX)
United Therapeutics Corporation (UTHR)
PerkinElmer (RVTY)
Bio-techne Corporation (TECH)
Hca Holdings (HCA)
Healthequity (HQY)
Pfizer (PFE)
Celldex Therapeutics Com New (CLDX)
Community Health Systems (CYH)

View all positions for Eversept Partners

Top funds holding Viatris

Vanguard Group
BlackRock
State Street Corporation
Davis Selected Advisers
T. Rowe Price Associates
Invesco
Geode Capital Management
Pacer Advisors
Deerfield Management Company
Ameriprise Financial
Rubric Capital Management
Morgan Stanley
Camber Capital Management
Dimensional Fund Advisors
AustralianSuper Pty

View all funds holding Viatris